Clinical Trial Update: A Study of KD6005 in Healthy Participants and Participants With Rheumatoid Arthritis (RA) [Phase 1]

View source ↗

Summary

A Phase 1 study of KD6005 in healthy participants and people with rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• KD6005

Snippet

Sponsor: Shanghai Kanda Biotechnology Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED